Huaren Pharmaceutical Co., Ltd. (SHE:300110)

China flag China · Delayed Price · Currency is CNY
3.300
+0.050 (1.54%)
Mar 10, 2026, 3:04 PM CST
7.84%
Market Cap 3.90B
Revenue (ttm) 1.26B
Net Income (ttm) -1.41B
Shares Out 1.18B
EPS (ttm) -1.19
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 19,169,508
Average Volume 22,805,221
Open 3.270
Previous Close 3.250
Day's Range 3.250 - 3.310
52-Week Range 2.710 - 3.750
Beta 0.44
RSI 53.04
Earnings Date Apr 24, 2026

About Huaren Pharmaceutical

Huaren Pharmaceutical Co., Ltd. produces and sells non-PVC soft bag infusions in China. It offers doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, and caffeine citrate, sodium chloride, glucose, glucose sodium potassium, chloride, compound sodium chloride, sodium lactate ringer, compound electrolyte, and sterilized water injections. The company also provides therapeutic infusion products for blood volume expansion, hemostasis, nervous and circulatory systems, anti-infection, anti-hepatitis, hepatitis adjuvant, ant... [Read more]

Sector Healthcare
Founded 1998
Employees 2,491
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300110
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.